The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Inclusion of HPV testing in routine cervical cancer screening for women above 29 years in Germany: results for 8466 patients
Open accessAbstract
In a prospective cohort study 8466 women attending routine cervical cancer screening were recruited. Colposcopy was performed on women with any degree of atypia on cytology and/or a positive high-risk human papillomavirus (HPV)-DNA test (HC2; Hybrid Capture 2((c))), and for a randomly selected sample of 3.4% women with negative findings on both. Quality control included reviews of cytology, histology, colposcopy images and retesting of samples with polymerase chain reaction. Test diagnostic performances were based on 7908 women who had complete baseline and follow-up results. Routine histology identified 86 women with high-grade cervical intraepithelial neoplasia (CIN2+), which was confirmed by review histology in only 46 cases. Sensitivity of routine cytology for the detection of CIN2+ was 43.5%, with a specificity, positive predictive value (PPV), negative predictive value (NPV) of 98.0, 11.4 and 99.7%, respectively. Sensitivity of the HC2 test for the detection of CIN2+ was 97.8%, with a specificity, PPV and NPV, of 95.3, 10.9 and 100%, respectively. No high-grade neoplasia was detected in the randomly selected control group. A negative HPV-test result, even in combination with a positive Papanicolaou (Pap) result, virtually excluded any risk of underlying high-grade disease, but this was not the case for a negative Pap result. These data show that HPV testing is of value for the detection or exclusion of prevalent CIN in a routine cervical cancer-screening setting and could be used for further risk classification of women for follow-up management.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective
Bosch, F. X., Manos, M. M., Munoz, N., Sherman, M., Jansen, A. M., Peto, J., Schiffman, M. H., Moreno, V., Kurman, R., Shan, K. V., et al. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.11.796 · Cited by 3,370
Solomon, D., Schiffman, M., & Tarone, R. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.4.293 · Cited by 975
Persistent Genital Human Papillomavirus Infection as a Risk Factor for Persistent Cervical Dysplasia
Ho, G. Y. F., Burk, R. D., Klein, S., Kadish, A. S., Chang, C. J., Palan, P., Basu, J., Tachezy, R., Lewis, R., & Romney, S. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.18.1365 · Cited by 803
Schiffman, M., Herrero, R., Hildesheim, A., Sherman, M. E., Bratti, M., Wacholder, S., Alfaro, M., Hutchinson, M., Morales, J., Greenberg, M. D., et al. (2000) · JAMA · doi:10.1001/jama.283.1.87 · Cited by 540 · cited 2×
“…team of specialists for collecting samples and reading Pap smears indeed found a higher sensitivity for cytology for high-grade cervical neoplasia (Schiffman et al, 2000; Clavel et al, 2001) than observed here or in recent studies that evaluated routine Pap smears (Ratnam et al, 2000; Schneider…”
MethodClavel, C., Masure, M., Bory, J.-P., Putaud, I., Mangeonjean, C., Lorenzato, M., Nazeyrollas, P., Gabriel, R., Quereux, C., & Birembaut, P. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1845 · Cited by 465
Human Papillomavirus Infection Is Transient in Young Women: A PopulationBased Cohort Study
Evander, M., Edlund, K., Gustafsson, A., Jonsson, M., Karlsson, R., Rylander, E., & Wadell, G. (1995) · Journal of Infectious Diseases · doi:10.1093/infdis/171.4.1026 · Cited by 306
International trends in incidence of cervical cancer: II. Squamous-cell carcinoma
Vizcaino, A. P., Moreno, V., Bosch, F. X., Mu�oz, N., Barros-Dios, X. M., Borras, J., & Parkin, D. M. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000501)86:3<429::aid-ijc20>3.0.co;2-d · Cited by 285
HPV testing in primary screening of older women
Cuzick, J., Beverley, E., Ho, L., Terry, G., Sapper, H., Mielzynska, I., Lorincz, A., Chan, W.-K., Krausz, T., & Soutter, P. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690730 · Cited by 268
van Duin, M., Snijders, P. J. F., Schrijnemakers, H. F. J., Voorhorst, F. J., Rozendaal, L., Nobbenhuis, M. A. E., van den Brule, A. J. C., Verheijen, R. H. M., Helmerhorst, T. J., & Meijer, C. J. L. M. (2002) · International Journal of Cancer · doi:10.1002/ijc.10232 · Cited by 260
Human papillomavirus testing for primary screening of cervical cancer precursors.
Ratnam, S., Franco, E. L., & Ferenczy, A. S. (2000) · PubMed · Cited by 240
Schneider, A., Hoyer, H., Lotz, B., Leistritza, S., Kühne-Heid, R., Nindl, I., Müller, B., Haerting, J., & Dürst, M. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20001120)89:6<529::aid-ijc11>3.0.co;2-g · Cited by 222
Peyton, C. L., Schiffman, M., Lörincz, A. T., Hunt, W. C., Mielzynska, I., Bratti, C., Eaton, S., Hildesheim, A., Morera, L. A., Rodriguez, A. C., et al. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.11.3248-3254.1998 · Cited by 210
Vernon, S. D., Unger, E. R., & Williams, D. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.2.651-655.2000 · Cited by 141 · cited 2×
“One contributing factor to the low specificity is the crossreactivity of the HC2 high-risk hybridisation probe with low-risk HPV types or HPV types of undetermined risk as discussed in earlier studies (Peyton et al, 1998; Vernon et al, 2000; Solomon et al, 2001).”
BackgroundHuman papillomavirus in a necessary cause of invasive cervical cancer worldwide
(1999) · Pure Amsterdam UMC · doi:10.1002/(sici)1096-9896(199909)189:1 · Cited by 140
Efficacy of cervical-smear collection devices: a systematic review and meta-analysis
Martin‐Hirsch, P. L., Lilford, R. J., Jarvis, G. J., & Kitchener, H. C. (1999) · The Lancet · doi:10.1016/s0140-6736(99)02353-3 · Cited by 117
Rozendaal, L., Westerga, J., van der Linden, J. C., Walboomers, J. M. M., Voorhorst, F. J., Risse, E. K. J., Boon, M. E., & Meijer, C. J. L. M. (2000) · Journal of Clinical Pathology · doi:10.1136/jcp.53.8.606 · Cited by 98
Tieben, L. M., MBERKHOUT, R. J., Smits, H. L., Bavinck, J. N. B., Vermeer, B. J., BRUIJN, J. A., van der Woude, F. J., & ter Schegget, J. (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1994.tb08496.x · Cited by 96
Schneider, A., Zahm, D. M., Kirchmayr, R., & Schneider, V. L. (1996) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(96)70602-6 · Cited by 89
Kornegay, J., Shepard, A. P., Hankins, C. A., Franco, E. L., Lapointe, N., Richardson, H., The Canadian Women's HIV Study Group, & Coutlée, F. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.10.3530-3536.2001 · Cited by 30
Cited by
de Sanjosé, S., Diaz, M., Castellsagué, X., Clifford, G., Bruni, L., Muñoz, N., & Bosch, F. X. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70158-5 · Cited by 1,669
Practice Bulletin No. 183: postpartum hemorrhage
(2017) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002351 · Cited by 1,406
Cuzick, J., Clavel, C., Petry, K., Meijer, C. J. L. M., Hoyer, H., Ratnam, S., Szarewski, A., Birembaut, P., Kulasingam, S., Sasieni, P., et al. (2006) · International Journal of Cancer · doi:10.1002/ijc.21955 · Cited by 1,141
Self-citationHuman Papillomavirus DNA versus Papanicolaou Screening Tests for Cervical Cancer
Mayrand, M.-H., Duarte-Franco, E., Rodrigues, I., Walter, S. D., Hanley, J., Ferenczy, A., Ratnam, S., Coutlée, F., & Franco, E. L. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa071430 · Cited by 1,100
Screening for cervical cancer: U.S. preventive services Task force recommendation statement
Moyer, V. A., & on behalf of the U.S. Preventive Services Task Force* (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-12-201206190-00424 · Cited by 1,049
Metadata
- Authors
- Petry, K.-U., Menton, S., Menton, M., van Loenen-Frosch, F., de Carvalho Gomes, H., Holz, B., Schopp, B., Garbrecht-Buettner, S., Davies, P., Boehmer, G., van den Akker, E., & Iftner, T.
- Venue
- British Journal of Cancer
- Published
- 2003-05
- Volume
- 88
- Issue
- 10
- Pages
- 1570-1577
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W2078962171
- Cited by
- 300
- References
- 19
- FWCI
- 17.94
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.